CAMBRIDGE, Mass.--(BUSINESS WIRE)--Javelin Pharmaceuticals Inc. (AMEX: JAV) today announced that its Board of Directors recently voted to increase the size of the Board from seven members to eight, and that it has elected Peter D. Kiernan, III, to fill the newly created directorship. Mr. Kiernan was qualified by the Board as an independent director.
